Randomised trial to evaluate the clinical value of intensive glucose monitoring and regulation in Acute Coronary Syndromes - BIOMArCS Project II; Glucose regulation

Medisch Centrum Alkmaar0 个研究点目标入组 300 人开始时间: 待定最近更新: 2024年5月13日

试验速览

暂无简介。

•1. A history of insulin dependent diabetes mellitus (note that patients with non-insulin dependent diabetes mellitus can be included).
•2. Myocardial ischemia precipitated by a condition other than atherosclerotic coronary artery disease (e.g. arrhythmia, severe anemia, hypoxia, thyrotoxicosis, cocaine, severe valvular disease, hypotension).
•3. Known severely-impaired left ventricular function (ejection fraction <30%) or end-stage congestive heart failure NYHA-class III or IV at presentation (in order to avoid lost-to-follow-up due to non-acute coronary syndrome events).
•4. Severe chronic kidney disease with measured or calculated glomerular filtration rate (Cockgroft-Gault or MDRD4 (Modification of Diet in Renal Disease) formula) of <30 ml/min/1.73m2, or renal dialysis40.
•5. Co-existent condition associated with a life-expectancy <1 year.
•6. Patient is expected to be transferred to another hospital within 48 hours.

发起方

Medisch Centrum Alkmaar